Aptamer Group PLC

Research Aptamer Group PLC (APTA) on Bullrun: market cap GBX 1.90B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerAPTA
• ExchangeLSE
• CountryUnited Kingdom
• SectorHealthcare
• IndustryBiotechnology
• CurrencyGBX
• Market capGBX 1.90B
• Financial periodFY2025
• RevenueGBP 1.20M
• Revenue growth39.9%
• Net income-GBP 2.42M
• Free cash flow-GBP 2.04M
• Gross margin48.1%

Valuation Snapshot

latest market cap is GBX 1.90B.

About Aptamer Group PLC

Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therapeutic applications.

Frequently asked questions

What is Aptamer Group PLC's market cap?

Aptamer Group PLC's market capitalization is GBX 1.90B.

What does Aptamer Group PLC do?

Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.